Why the study?
The potential impact of renal function-related cardiovascular remodeling on associated cardiovascular risk had not been previously investigated.
Does lower renal function increase the risk of cardiovascular events, and is this mediated by adverse cardiac remodeling?
Does lower renal function increase the risk of cardiovascular events, and is this mediated by adverse cardiac remodeling?
Adverse left ventricular remodeling and cardiometabolic diseases independently mediate the relationship between reduced renal function and increased risk of cardiovascular events.
Lower eGFR-cysC may raise CV risk via remodeling; observational mediation leaves causal pathways and practice change open.
The potential impact of renal function-related cardiovascular remodeling on associated cardiovascular risk has not been previously investigated. Hence, we conducted multiple mediation analyses in the UK Biobank study to evaluate this association. Using multiple Cox models, we found lower renal function (estimated glomerular filtration rate based on cystatin C, eGFR-cysC) was independently related to increased risks of various cardiovascular events and mortalities. Multivariable linear regression revealed a progressive relationship between declining eGFR-cysC and adverse left ventricular (LV) remodeling and impaired systolic function. In Cox models, larger LV volume, mass, as well as decreased systolic function, were significantly correlated with adverse events, particularly in heart failure. Mediation analyses showed that undesirable LV remodeling and cardiometabolic diseases were independent mediators. Our study explores the connections between reduced renal function and poor cardiovascular phenotypes, as well as their significant independent role in mediating renal function-cardiovascular outcome relationships.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: